{"id":"clm_E9DC797FB50C","entity":"pfizer","predicate":"cash_and_equivalents","value":"2,470,000,000 United States dollar","value_json":{"fp":"Q1","fy":2022,"accn":"0000078003-22-000071","form":"10-Q","filed":"2022-05-11","period":"Q1 FY2022","concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue"},"valid_from":"2022-04-03","valid_to":"2022-07-03","published":"2022-05-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Pfizer cash and equivalents: 2,470,000,000 United States dollar\", as of 2022-04-03 (until 2022-07-03). Claim clm_E9DC797FB50C, https://asof.is/claim/clm_E9DC797FB50C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/78003/000007800322000071/0000078003-22-000071-index.htm.","url":"https://asof.is/claim/clm_E9DC797FB50C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5481970B0F0A","supersedes":["clm_5494D0A65D17"],"first_seen_at":"2026-11-08T16:58:25.959946+00:00","updated_at":"2026-11-08T16:58:29.361836+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800322000071/0000078003-22-000071-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2022-05-11"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}